Internal Medicine, Endocrinology, Diabetes, & Metabolism · New Hyde Park, NY
NPI
1285600973
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
1999 Marcus Ave Ste 212
New Hyde Park, NY, 11042
Phone (516) 467-8600
Groups this clinician bills Medicare through
Medicare paid, 2024
$547K
15,795 services
Medicare patients, 2024
1,501
Average age 76
Drug cost, 2024
$4.3M
8,551 prescriptions
Company payments, 2025
$683
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rory S Breidbart was code J0897 (injection, denosumab, 1 mg), 6,840 times for 69 patients. In total Rory S Breidbart billed 15,795 services in 19 codes, and Medicare paid $547K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 6,840 | 69 | $20.55 | $141K |
| 36415 Venipuncture Blood Collection | Office | 2,377 | 1,092 | $8.61 | $20K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 2,173 | 1,050 | $14.06 | $31K |
| 99214 Office E&M - Established | Office | 2,051 | 891 | $104.79 | $215K |
| 99213 Office E&M - Established | Office | 788 | 516 | $74.35 | $59K |
| 95251 Test - Miscellaneous | Office | 551 | 197 | $28.01 | $15K |
| 99232 Hospital E&M - Subsequent | Facility | 464 | 196 | $70.15 | $33K |
| 99203 Office E&M - New | Office | 143 | 143 | $95.66 | $14K |
| 96372 Injection Administration | Office | 129 | 73 | $12.22 | $1,576 |
| 99231 Hospital E&M - Subsequent | Facility | 129 | 64 | $44.11 | $5,690 |
| 99222 Hospital E&M - Initial | Facility | 72 | 68 | $115.64 | $8,326 |
| 99221 Hospital E&M - Initial | Facility | 38 | 38 | $74.55 | $2,833 |
| 99212 Office E&M - Established | Office | 13 | 12 | $48.12 | $626 |
By year: 2022 $482K for 12,444 services; 2023 $508K for 12,642 services; 2024 $547K for 15,795 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 2,377 | 1,092 | $8.61 | $20K |
Medicare prescription drug claims, 2024
In 2024, the drug Rory S Breidbart prescribed most often to Medicare patients was Mounjaro (Tirzepatide), with 1,017 prescriptions and refills. In total Rory S Breidbart wrote 8,551 Medicare prescriptions that cost $4.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mounjaro Tirzepatide | 1,017 | 1,325 | 143 | $1.4M |
| Levothyroxine Sodium Generic | 894 | 2,352 | 252 | $16K |
| Synthroid Levothyroxine Sodium | 727 | 1,933 | 183 | $66K |
| Metformin Hcl Generic | 605 | 1,727 | 186 | $5,974 |
| Jardiance Empagliflozin | 316 | 706 | 85 | $404K |
| Atorvastatin Calcium Generic | 282 | 804 | 81 | $3,059 |
| Trulicity Dulaglutide | 273 | 370 | 47 | $354K |
| Januvia Sitagliptin Phosphate | 263 | 583 | 67 | $313K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 252 | 670 | 103 | $33K |
| Glimepiride Generic | 210 | 592 | 67 | $3,333 |
| Farxiga Dapagliflozin Propanediol | 181 | 435 | 51 | $240K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 152 | 373 | 44 | $25K |
| Ezetimibe Generic | 151 | 422 | 44 | $5,450 |
| Losartan Potassium Generic | 143 | 423 | 46 | $1,449 |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 141 | 377 | 44 | $166K |
Brand drugs: 4,729 claims; generic drugs: 3,410 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rory S Breidbart $683 ($683 in general payments such as food, travel and fees) from 9 companies. The largest payer was Abbott Laboratories with $219.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.